Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease

Chinese Medical Journal

Volumn 133, Issue 9, 2020, Pages 1032-1038

  Liu, Wei ^a   Tao, Zhao Wu ^a   Wang, Lei ^a   Yuan, Ming Li ^a   Liu, Kui ^a   Zhou, Ling ^a   Wei, Shuang ^a   Deng, Yan ^a   Liu, Jing ^a   Liu, Hui Guo ^a   Yang, Ming ^a   Hu, Yi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

2019 Novel coronavirus disease; Disease outcome; Predictors

Indexed keywords

ADULT; AGED; BETACORONAVIRUS; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; FEMALE; HOSPITAL; HUMAN; MALE; MIDDLE AGED; PANDEMIC; RISK FACTOR; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; STATISTICAL MODEL; VIRUS PNEUMONIA;

ADULT; AGED; BETACORONAVIRUS; CORONAVIRUS INFECTIONS; FEMALE; HOSPITALS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL; RISK FACTORS;

EID: 85082403258     PISSN: 03666999     EISSN: 25425641     Source Type: Journal    
DOI: 10.1097/CM9.0000000000000775     Document Type: Article

References (21)

1. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O,. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020; 91: 264-266. doi: 10.1016/j.ijid.2020.01.009.
2. Zhang N, Wang L, Deng X, Liang R, Su M, He C,. Recent advances in the detection of respiratory virus infection in humans. J Med Virol 2020; 92: 408-417. doi: 10.1002/jmv.25674.
3. Cumulative Number of Reported Cases of 2019 Novel Coronavirus Pneumonia. Beijing: National Health Commission of the People's Republic of China, 2020. Available from: http://www.nhc.gov.cn/xcs/yqtb/202002/d5c495da742f4739b7f99339c3bd032f.shtml. [Accessed February 2, 2020].
4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y,. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506. doi: 10.1016/S0140-6736(20)30183-5.
5. National Health Commission of the People's Republic of China, National Administration of Traditional Chinese Medicine of the People's Republic of China. Diagnosis and Treatment Protocol for Novel Coronavirus Infection-Induced Pneumonia Version 4 (trial). Available from: http://www.nhc.gov.cn/yzygj/s7653p/202001/4294563ed35b43209b31739bd0785e67/files/7a9309111267475a99d4306962c8bf78.pdf. [Accessed January 27, 2020].
6. Chen Y, Liu Q, Guo D,. Coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 2020; 92: 418-423. doi: 10.1002/jmv.25681.
7. Enserink M,. Infectious diseases. Clues to the animal origins of SARS. Science 2003; 300: 1351. doi: 10.1126/science.300.5624.1351a.
8. Hui DSC, Zumla A,. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect Dis Clin North Am 2019; 33: 869-889. doi: 10.1016/j.idc.2019.07.001.
9. Liu C, Chen Z, Hu Y, Ji H, Yu D, Shen W,. Complemented palindromic small RNAs first discovered from SARS coronavirus. Genes (Basel) 2018; 9: E442. doi: 10.3390/genes9090442.
10. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J,. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 20: 727-733. doi: 10.1056/NEJMoa2001017.
11. Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T,. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J 2020; 133: 1015-1024. doi: 10.1097/CM9.0000000000000722.
12. Ticinesi A, Nouvenne A, Folesani G, Prati B, Morelli I, Guida L,. An investigation of multimorbidity measures as risk factors for pneumonia in elderly frail patients admitted to hospital. Eur J Intern Med 2016; 28: 102-106. doi: 10.1016/j.ejim.2015.11.021.
13. Cilloniz C, Polverino E, Ewig S, Aliberti S, Gabarrus A, Menendez R,. Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Chest 2013; 144: 999-1007. doi: 10.1378/chest.13-0062.
14. Ladha KS, Zhao K, Quraishi SA, Kurth T, Eikermann M, Kaafarani HM,. The Deyo-Charlson and Elixhauser-van Walraven comorbidity indices as predictors of mortality in critically ill patients. BMJ Open 2015; 5: e008990. doi: 10.1136/bmjopen-2015-008990.
15. Mohamed R, Aleanizy FS, Alqahtani FY, Alanazi MS, Mohamed N,. Common co-morbidities are challenging in the diagnosis of middle east respiratory syndrome (MERS-CoV) in Saudi Arabia. Pak J Biol Sci 2020; 23: 119-125. doi: 10.3923/pjbs.2020.119.125.
16. Duc S, Rainfray M, Soubeyran P, Fonck M, Blanc JF, Ceccaldi J,. Predictive factors of depressive symptoms of elderly patients with cancer receiving first-line chemotherapy. Psychooncology 2017; 26: 15-21. doi: 10.1002/pon.4090.
17. Ho TS, Wang SM, Liu CC,. Historical review of pandemic influenza A in Taiwan, 2009. Pediatr Neonatol 2010; 51: 83-88. doi: 10.1016/S1875-9572(10)60016-2.
18. Wu CT, Hsia SH, Huang JL,. Influenza B-associated rhabdomyolysis in Taiwanese children. Acta Paediatr 2010; 99: 1701-1704. doi: 10.1111/j.1651-2227.2009.01595.x.
19. Kato S, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Suda T,. Severe respiratory failure associated with influenza B virus infection. Respirol Case Rep 2015; 3: 61-63. doi: 10.1002/rcr2.107.
20. Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J,. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 2015; 313: 677-686. doi: 10.1001/jama.2015.88.
21. Kil HR, Lee JH, Lee KY, Rhim JW, Youn YS, Kang JH,. Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus. Crit Care 2011; 15: 413. doi: 10.1186/cc10082.